The findings suggest that individuals with certain ACE2 genotypes, particularly those with hypertension, are at a higher risk for severe COVID-19 outcomes, emphasizing the importance of understanding genetic factors in managing both cardiovascular diseases and viral infections [64]. This evidence concerns the gene ACE2 and cardiovascular disorder.